Zoxflo-OZ Tablets contain a potent dual-combination of Ofloxacin (200mg) and Ornidazole (500mg), making them highly effective in treating a variety of gastrointestinal and genitourinary tract infections. These tablets are broad-spectrum antimicrobials known for their rapid action and high efficacy.
🔹 Composition (Per Tablet):
-
Ofloxacin IP – 200 mg: A fluoroquinolone antibiotic that disrupts bacterial DNA replication, offering rapid relief from infections.
-
Ornidazole IP – 500 mg: Effective against anaerobic bacteria and protozoa like Giardia and Entamoeba, making it suitable for mixed infections.
🔹 Indications:
-
Diarrhea and dysentery
-
Amoebiasis
-
Giardiasis
-
Pelvic inflammatory disease
-
Intra-abdominal infections
-
Dental and post-surgical infections
🔹 Key Benefits:
-
Dual action: antibacterial + antiprotozoal
-
Fast relief from gastrointestinal distress
-
Minimal resistance and side effects
-
Prescribed widely in gastroenterology and general practice
🔹 Why Stock Zoxflo-OZ for PCD Franchise:
-
High prescription value and wide application
-
Attractive 10×10 packaging for visual appeal
-
Excellent shelf life and brand trust
-
Monopoly distribution available
-
Competitive pricing with high ROI for franchisees
Zoxflo-OZ is an ideal addition for any PCD pharma franchise business focused on antibiotics or gastro-intestinal care. Its reliability and effectiveness make it a best-seller in both government and private healthcare sectors.
